Clinical Trial Update: Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability and efficacy of a depigmented modified allergen extract from two mites in subjects with allergic rhinitis or rhino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Rhinoconjunctivitis

Drugs mentioned

• Depigmented Modified Allergen Extract (two mites)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Rhinitis, Rhinoconjunctivitis | Phase 2 | Status: COMPLETED